NKG2A and COVID-19: another brick in the wall.

Antonioli, Luca; Fornai, Matteo; Pellegrini, Carolina; Blandizzi, Corrado

Antonioli, Luca; Fornai, Matteo; Pellegrini, Carolina; Blandizzi, Corrado.

Antonioli L; Department of Clinical and Experimental Medicine, University of Pisa, 56126, Pisa, Italy. lucaant@gmail.com.
Fornai M; Department of Clinical and Experimental Medicine, University of Pisa, 56126, Pisa, Italy.
Pellegrini C; Department of Pharmacy, University of Pisa, 56126, Pisa, Italy.
Blandizzi C; Department of Clinical and Experimental Medicine, University of Pisa, 56126, Pisa, Italy.

Cell Mol Immunol ; 17(6): 672-674, 2020 06.

Article in English | MEDLINE | ID: covidwho-220209

Subject(s)

Antiviral Agents; Killer Cells, Natural; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; NK Cell Lectin-Like Receptor Subfamily C; Pandemics; Pneumonia, Viral; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Killer Cells, Natural Limits: Humans Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41423-020-0450-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google